Federal Circuit remands Abbott drug test patent suit
14-04-2020
Bayer begins $240m AI drug discovery project with Exscientia
10-01-2020
natrot / Shutterstock.com
The US Court of Appeals for the Federal Circuit has overturned a lower court’s decision to find a heart monitoring patent invalid under Alice, handing a win to medical laboratory company BioTelemetry.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
US Court of Appeals for the Federal Circuit, cardiac monitoring, patent, Alice, CardioNet, BioTelemetry, InfoBionic
